首頁 > 市場調查報告書 > 製藥

生物製劑

市場調查報告書

商品編碼

1746731

日本血漿分餾市場報告（按產品、產業、應用、最終用戶和地區）2025-2033

Japan Plasma Fractionation Market Report by Product, Sector, Application, End User, and Region 2025-2033

出版日期: 2025年06月02日 | 出版商:

IMARC | 英文 115 Pages | 商品交期: 5-7個工作天內

價格

簡介目錄

2024年，日本血漿分離市場規模達9.029億美元。展望未來， IMARC Group預計到2033年，該市場規模將達到17.023億美元，2025-2033年期間的複合年成長率（CAGR）為6.7%。政府機構越來越重視引進經濟高效的病毒去活化技術，以安全利用本地血漿資源，這是推動市場成長的主要動力。

血漿分離是將捐贈血漿轉化為至關重要的救命治療藥物和醫療產品的過程。它涉及透過離心、深層過濾、沉澱和色譜等機械分離技術將血漿分離成單一蛋白質或血漿級分。在現代分離製程中，人們採用各種方法來分離特定的治療性蛋白質，包括調整酒精濃度、時間、溫度和pH值。此外，隨著時間的推移，技術複雜性的提高以及在製造過程中實施病毒殺滅處理，催生了新型蛋白質療法的出現，並提高了產品的純度和品質。

日本血漿分餾市場趨勢：

源自人體血漿的蛋白質產品是一類重要的治療手段，廣泛應用於預防、管理和治療危及生命的疾病，包括感染、先天性缺陷、罕見血液疾病、免疫性疾病和自體免疫疾病。這些疾病在相當一部分人口中的盛行率大幅上升，是市場擴張的主要驅動力。此外，為了應對各國監管機構強制實施的嚴格法規和品質控制措施，製造商正在將額外的安全特性融入血漿分離流程，這對區域市場產生了積極影響。此外，市場利害關係人正在將資金投入到旨在推進血漿生產技術的研發項目中，從而成為重要的成長促進因素。這些努力旨在提高產品功效，並促進免疫球蛋白G (IgG) 的回收，以分離新型血漿蛋白。此外，他們也致力於開發經濟高效的病毒去活化和處理技術，以確保安全利用本地血漿資源。再加上對最佳化產量、維持製程成本效益和遵守日益嚴格的監管標準的日益成長的需求，這將在未來幾年創造良好的市場前景。

日本血漿分餾市場細分：

產品洞察：

免疫球蛋白
白蛋白
凝血因子VIII
凝血因子 IX

產業洞察：

私部門
公部門

應用程式洞察：

神經病學
免疫學
血液學
其他

最終用戶洞察：

醫院和診所
臨床研究實驗室
學術機構

競爭格局：

市場研究報告也對競爭格局進行了全面的分析。報告涵蓋了市場結構、關鍵參與者定位、最佳制勝策略、競爭儀錶板和公司評估象限等競爭分析。此外，報告還提供了所有主要公司的詳細資料。

本報告回答的關鍵問題：

日本血漿分離市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本血漿分餾市場有何影響？
日本血漿分離市場依產品分類是怎樣的？
日本血漿分離市場依產業分類的狀況如何？
日本血漿分離市場根據應用的細分是怎樣的？
根據最終用戶，日本血漿分離市場是如何分類的？
日本血漿分離市場的價值鏈分為哪些階段？
日本血漿分離技術的關鍵促進因素和挑戰是什麼？
日本血漿分離市場的結構是怎麼樣的？主要參與者是誰？
日本血漿分離市場的競爭程度如何？

本報告回答的關鍵問題：

日本血漿分離市場迄今表現如何？未來幾年將如何表現？
COVID-19 對日本血漿分餾市場有何影響？
日本血漿分離市場依產品分類是怎樣的？
日本血漿分離市場依產業分類的狀況如何？
日本血漿分離市場根據應用的細分是怎樣的？
根據最終用戶，日本血漿分餾市場是如何分類的？
日本血漿分離市場的價值鏈分為哪些階段？
日本血漿分離技術的關鍵促進因素和挑戰是什麼？
日本血漿分離市場的結構是怎麼樣的？主要參與者是誰？
日本血漿分離市場的競爭程度如何？

Japan plasma fractionation market size reached USD 902.9 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,702.3 Million by 2033, exhibiting a growth rate (CAGR) of 6.7% during 2025-2033. The rising focus among government bodies to introduce cost-effective viral inactivation technologies to safely utilize local plasma resources is primarily driving the market growth.

Plasma fractionation is the process of converting donated plasma into crucial life-saving treatments and medical products. It involves the division of plasma into individual proteins or plasma fractions through mechanical separation techniques like centrifugation, depth filtration, precipitation, and chromatography. In contemporary fractionation processes, various methods including alcohol concentrations, time, temperature, and pH adjustments are employed to isolate particular therapeutic proteins. Furthermore, the advancement of technology complexity over time and the implementation of viral reduction treatments during the manufacturing process have led to the emergence of novel protein therapies and enhancements in the purity and quality of products.

Japan Plasma Fractionation Market Trends:

Protein products derived from human plasma constitute a vital category of therapies extensively employed for the prevention, management, and treatment of life-threatening conditions, encompassing infections, congenital deficiencies, rare blood disorders, immunologic ailments, and autoimmune disorders. A significant upsurge in the prevalence of these conditions within a substantial portion of the population serves as a primary driver underpinning market expansion. Furthermore, manufacturers are incorporating added safety features into plasma fractionation procedures in response to stringent regulations and quality control measures mandated by regulatory agencies in numerous countries, which is positively influencing the regional market. Additionally, market stakeholders are directing financial resources towards research and development (R&D) initiatives aimed at advancing plasma production technology, thereby acting as significant growth-inducing factors. These endeavors aim to enhance product effectiveness and boost the recovery of immunoglobulin G (IgG) for the isolation of novel plasma proteins. Furthermore, they are focusing on developing cost-effective viral inactivation and processing technologies that enable the safe utilization of local plasma resources. This, in combination with the growing imperative to optimize yield, maintain process cost-efficiency, and comply with increasingly stringent regulatory standards, is poised to create a favorable market outlook in the forthcoming years.

Japan Plasma Fractionation Market Segmentation:

Product Insights:

Immunoglobulins
Albumin
Coagulation Factor VIII
Coagulation Factor IX

Sector Insights:

Private Sector
Public Sector

Application Insights:

Neurology
Immunology
Hematology
Others

End User Insights:

Hospitals and Clinics
Clinical Research Laboratories
Academic Institutes

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

How has the Japan plasma fractionation market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the Japan plasma fractionation market?
What is the breakup of the Japan plasma fractionation market on the basis of product?
What is the breakup of the Japan plasma fractionation market on the basis of sector?
What is the breakup of the Japan plasma fractionation market on the basis of application?
What is the breakup of the Japan plasma fractionation market on the basis of end user?
What are the various stages in the value chain of the Japan plasma fractionation market?
What are the key driving factors and challenges in the Japan plasma fractionation?
What is the structure of the Japan plasma fractionation market and who are the key players?
What is the degree of competition in the Japan plasma fractionation market?

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Japan Plasma Fractionation Market - Introduction

4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Japan Plasma Fractionation Market Landscape

5.1 Historical and Current Market Trends (2019-2024)
5.2 Market Forecast (2025-2033)

6 Japan Plasma Fractionation Market - Breakup by Product

6.1 Immunoglobulins
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
6.2 Albumin
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
6.3 Coagulation Factor VIII
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
6.4 Coagulation Factor IX
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)

7 Japan Plasma Fractionation Market - Breakup by Sector

7.1 Private Sector
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
7.2 Public Sector
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)

8 Japan Plasma Fractionation Market - Breakup by Application

8.1 Neurology
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
8.2 Immunology
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
8.3 Hematology
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
8.4 Others
- 8.4.1 Historical and Current Market Trends (2019-2024)
- 8.4.2 Market Forecast (2025-2033)

9 Japan Plasma Fractionation Market - Breakup by End User

9.1 Hospitals and Clinics
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
9.2 Clinical Research Laboratories
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
9.3 Academic Institutes
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)

10 Japan Plasma Fractionation Market - Competitive Landscape

10.1 Overview
10.2 Market Structure
10.3 Market Player Positioning
10.4 Top Winning Strategies
10.5 Competitive Dashboard
10.6 Company Evaluation Quadrant

11 Profiles of Key Players

11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Services Offered
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Services Offered
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Services Offered
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Services Offered
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Services Offered
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events

12 Japan Plasma Fractionation Market - Industry Analysis

12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
12.3 Value Chain Analysis